Quest Diagnostics Inc.’s DGX investments in Advanced Diagnostics are paying off, aiming to deliver and scale innovative services that improve patient care and drive growth. The company focuses on ...
Shares of Quest Diagnostics Inc. DGX shed 1.39% to $173.12 Monday, on what proved to be an all-around rough trading session for the stock market, with the S&P 500 Index SPX falling 2.70% to 5,614. ...
Quest Diagnostics Inc. DGX benefits from its robust utilization of the Advanced Diagnostics portfolio offerings. The company also expands through strategic acquisitions, completing eight ...